Please assess the completion status of the following clinical trial:

Trial Title: Ultrasound and EMG Guided Botox Injection for the Treatment of Non-Relaxing Puborectalis Syndrome

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Female~* 18 years of age or older~* Diagnosis of non-relaxing puborectalis syndrome~Exclusion Criteria:~* Allergy or sensitivity to botulinum toxin~* Pregnancy or plan to become pregnant in the subsequent 6 months after injection~* Undiagnosed ano-rectal mass, lesion, or infection~* Stage II or greater rectocele

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Botulinum toxin (Botox) injection (Type: EXPERIMENTAL): All patients will be given the active Botox injection and thus this study will remain open-label and non-randomized as this is a pilot study to determine initial efficacy.

Based on this trial design, predict the completion outcome and termination type (if applicable).